Eli Lilly to sell dog drug assets to Virbac to secure approval for purchase of Novartis animal health unit
MLex Summary: Pharmaceutical companies Eli Lilly and Novartis have agreed to divest certain assets related to two major parasiticides for dogs in order to secure approval from the US Federal Trade...To view the full article, register now.
Already a subscriber? Click here to view full article